Catheter Precision (VTAK) Notes Payables (2020 - 2026)

Catheter Precision (VTAK) has 6 years of Notes Payables data on file, last reported at $6.5 million in Q1 2026.

• Notes Payables for Q1 2026 came in at $6.5 million, up 308.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 308.75% YoY), and the FY2024 annual result was $177000.0, down 3.8% from the prior year.
• Notes Payables improved to $6.5 million in Q1 2026 per VTAK's latest filing, from $26000.0 in the prior quarter.
• Over five years, Notes Payables peaked at $14.2 million in Q2 2023 and troughed at $7592.0 in Q1 2023.
• A 4-year average of $4.1 million and a median of $249000.0 in 2024 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2024 and 2026: Notes Payables slumped 98.24% in 2024, then jumped 308.75% in 2026.
• A 4-year view of Notes Payables shows it stood at $184000.0 in 2023, then decreased by 3.8% to $177000.0 in 2024, then sank by 85.31% to $26000.0 in 2025, then surged by 25053.85% to $6.5 million in 2026.
• Business Quant data shows VTAK's Notes Payables at $6.5 million in Q1 2026, $26000.0 in Q2 2025, and $1.6 million in Q1 2025.